Case Reports on Hematomas
Case Reports on Hematomas is a research topic within Surgery. Science Explorer counts 9.3k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the management of spontaneous and iatrogenic hematomas, including retroperitoneal and rectus sheath hematomas. The papers discuss conservative management, endovascular intervention, and open surgery as treatment options, particularly in patients undergoing anticoagulant therapy. Additionally, the cluster explores complications such as femoral neuropathy and the differential diagnosis with soft tissue sarcomas.
- Hematoma
- Management
- Endovascular Intervention
- Conservative Treatment
- Rectus Sheath Hematoma
- Anticoagulant Therapy
- Femoral Neuropathy
- Embolization
- Soft Tissue Sarcoma
- Retroperitoneal Hemorrhage
- Research works
- 9.3k fractional, since 1950
- In the world top 10%
- 946 per year above
- Top-10% rate
- 10.1% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- -3% the tick is no change
- Largest producer
United States
33% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Case Reports on Hematomas research?
By volume, the United States and China publish the most (338 and 155 works in 2022-now).
By volume, 2022-now
- 1
United States
338 works
- 2
China
155 works
- 3
Japan
151 works
- 4
India
108 works
- 5
Germany
58 works
- 6
United Kingdom
57 works
- 7
Spain
44 works
- 8
Italy
43 works
- 9
South Korea
39 works
- 10
Türkiye
35 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Case Reports on Hematomas research?
By volume in 2022-now, All India Institute of Medical Sciences publishes the most Case Reports on Hematomas research, followed by Mount Sinai Health System and Harvard University.
By volume, 2022-now
- 1
All India Institute of Medical SciencesIndia
11 works
- 2
Mount Sinai Health SystemUnited States
10 works
- 3
Harvard UniversityUnited States
10 works
- 4
Mayo ClinicUnited States
9 works
- 5
Mohammed V University
Morocco
6 works
- 6
Sichuan UniversityChina
6 works
- 7
United States Department of Veterans AffairsUnited States
6 works
- 8
Yale UniversityUnited States
5 works
- 9
Northwell HealthUnited States
5 works
- 10
Zhejiang UniversityChina
4 works
Who are the leading researchers in Case Reports on Hematomas?
The most-cited researchers publishing on Case Reports on Hematomas include Gregory Y.H. Lip, Salim Yusuf and Jasvinder A. Singh.
- 1
Gregory Y.H. Lip
United Kingdom
311k citations
- 2
Salim Yusuf
Canada
294k citations
- 3
Jasvinder A. Singh
United States
247k citations
- 4
Patrizio Lancellotti
Belgium
245k citations
- 5
Alberto Arduan Ortiz
Spain
219k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Case Reports on Hematomas research done?
The largest centres of Case Reports on Hematomas research in 2022-now are Tokyo (Japan), New York (United States), Beijing (China) and Seoul (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Tokyo and New York.
Largest cities, 2022-now
Where it is the local speciality
- TokyoJP · 30.0 works2.5×
- New YorkUS · 21.9 works2.1×
Location quotient: how much more of its research is in Case Reports on Hematomas than the world average.
Where is the best place to study Case Reports on Hematomas?
Among universities, judged by research, Harvard University and All India Institute of Medical Sciences score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Harvard UniversityUnited States |
53.3 | 11.7% | 2.3× | 10 | -6.7% |
| 2 | All India Institute of Medical SciencesIndia |
47.5 | 6.0% | 7.7× | 11 | +10.0% |
Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Case Reports on Hematomas, country by countryIs Case Reports on Hematomas research growing?
Output in 2022-2025 was 3% lower than in 2018-2021, peaking in 2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Case Reports on Hematomas as a percentage of every work published that year, 0.0067% in 2024.
Fractional works of Case Reports on Hematomas over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Case Reports on Hematomas. Posts are plain text and can be reported.